Our international network ensures that we have a ready resource of expertise in key jurisdictions and that we are well positioned to advise on cross-border work, in relation to both contentious and non-contentious matters.
Our advice covers intellectual property, both contentious and non-contentious, mergers and acquisitions, commercial transactions (including licensing and collaborations), capital markets and finance and regulatory matters.
Vaccination efforts have been met with some controversy since their inception, on ethical, political, medical safety, religious, and other grounds. Early success and compulsion brought widespread acceptance and mass vaccination campaigns were undertaken which are credited with greatly reducing the incidence of many diseases in numerous geographic regions. The eradication of smallpox, which was last seen in a natural case in 1977, is considered the most evident success of vaccination.
Our clients include Novartis Vaccines and GlaxoSmithKline.